| Income Statement | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|
| Total operating expenses | 14,300 | 24,027 | 15,710 | |
| Net loss | -30,092 | -39,472 | -32,004 | |
| Basic eps | 0 | 0 | 0 | |
| Diluted eps | 0 | 0 | 0 | |
| Basic average shares | 70,772,196 | 70,765,603 | 70,472,196 | |
| Diluted average shares | 70,772,196 | 70,765,603 | 70,472,196 | |
NEXIEN BIOPHARMA, INC. (NXEN)
NEXIEN BIOPHARMA, INC. (NXEN)